Lymphoid NSSG Resources

Lymphoma Protocols

A-D ---------------------------- ABVD - L.8 Alemtuzumab - L.88 BCNU Thiotepa (high dose) (B.35) BEACOPDac-14 or BEACOPDac-Escalated - L.95 Bendamustine-R for NHL - L.45 Bexarotene - L.99 BR-Acalabrutinib - L.157 Brentuximab vedotin - L. 9 Brentuximab vedotin in combination with CHP - L. 127 BV-AVD - L.154 BVB - L.158 Chlorambucil +/- R - L.26 ChlVPP - L.79 CHOP-14 / R-CHOP - L.48 CHOP-21 / R-CHOP-21 - L. 80 Cladribine - L.28 Cyclophosphamide Oral (L.134) Cytarabine (high dose) +/- R (L.54) Cytarabine (intrathecal) (L.55) DA-EPOCH-R (L.66) DDGP (L.112) DRC - L.17 Doxorubicin for urgent use - L.58

E-O ---------------------------- Epcoritamab - L.151 ESHAP / R-ESHAP - L.35 Gemcitibine Monotherapy - L.128 Glofitamab - L.149 Glofit-GemOx - L.155 Ibrutinib - L.38 Idelalsib + Rituximab - L.7 Loncastuximab tesirine (Lonca-T) - L.150 Modified R-ICE - L.116 Marietta (off study) - L.152 R-MA (MARTA off study) - L.153 MATRix - L.33 MaxiCHOP / Ara-C + R - L.84 Methotrexate (high dose) for CNS prophylaxis - L.13 Methotrexate (intrathecal) - L.85 Methotrexate (weekly) - L.87 Mini-BEAM (modified) - L.30 Mogamulizumab - L.139 Nivolumab - L.90 Obinutuzumab and Bendamustine - L.91 O-CVP with Maintenance Obinutuzumab - L.98

P-Z ---------------------------- Pembrolizumab - L. 105 Pentostatin - L. 15 PEP-C - L. 107 Pola-R-CHP - L.144 Polatuzumab vedotin +Bendamustin +Rituximab (PBR) - L. 113 R-BAC - L.19 R-CHOP-21 / CHOP-21 - L.80 R-CHOP-I + R-DHAOx Induction / R-I Maintenance protocol - L.163 R-CODOX-M / R-IVAC - L.49 R-CVP - L.82 R-DHAOx (L.133) ESHAP / R-ESHAP (L.35) R-GCVP - L.31 R-GDP - L.62 R-GEMOx - L.100 R-ICE - L.24 R-MiniCHOP - L. 83 R-MP - L.145 R-VP - L.40 Rituximab Lenalidomide - L.122 Rituximab (maintenance) - L.41 Rituximab (single agent) - L.43 SMILE (L.67) Venetoclax and Obinutuzumab - L.130 Zanubrutinib - L.136

For a blank protocol template please click here.

CLL Protocols

Please choose ---------------------------- Acalabrutinib Monotherapy - L.124 Acalabrutinib with Venetoclax - L.162 Bendamustine-R for CLL - L.44 Ibrutinib - L.38 Ibrutinib + Ventoclax - L.148 Pirtobrutinib - L.140 R-Venetoclax - L.111 Zanubrutinib - L.136

For a blank protocol care plan template please click here.

Histiocytosis Protocols

Please choose ---------------------------- OUH Management of Haemophagocytic Lymphohistiocytosis (HLH) in Adults (full guideline) OUH Management of Haemophagocytic Lymphohistiocytosis (HLH) in Adults (2-page summary) Methotrexate oral +/- 6-MP +/- Indometacin - L.141 Methotrexate oral +/- 6-MP +/- Indometacin - L.141

For a blank protocol care plan template please click here.

Supportive Care

Please Choose ---------------------------- Bleomycin Supportive Care Guidelines (L.101) Bone protection in Lymphoma (L.132) Filgrastim - biosimilar (B.36) Ovarian Tissue Cryopreservation (OTCP) Referral Form (OVF03) Tocilizumab for CRS (H.126) Urgent Sperm Storage Referral Prior to Chemo/Radiotherapy

Patient Information

Please Choose ---------------------------- After your bone marrow biopsy (OMI 103611) CAR-T Cell Information for Patients (L.121) CLL CNS New Patient Information Sheet (L.102) Having a bone marrow test (OMI 91022) Lymphoma Telemed Invite Letter (L.73) OUH Vaccination Letter to GPs Treatment Pathway for cHL Early Stage Disease (LPW.20.1) Treatment Pathway for cHL Advanced Stage Disease (LPW.20.2) Clinical Nurse Specialist and Key Worker Booklet

Resources for Primary Care

Please Choose ---------------------------- CLL Guide for GPs Managing Stage A Patients (L.68) CLL GP Notification and Checklist (LPR.116) Lymphoma GP Notification and Checklist (LPR.116) Example letter to Dentist (H.83a)